{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:34:42Z","timestamp":1790120082361,"version":"4.0.1"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T00:00:00Z","timestamp":1684627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bloomberg Philanthropies\u2019 Stopping Tobacco Organizations and Products"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Heated tobacco products (HTPs) are marketed as less harmful alternatives to cigarettes, but the lung cancer risk of HTPs is unknown. In the absence of epidemiological data, assessing the risks of HTPs relies on biomarker data from clinical trials. This study examined existing biomarker data to determine what it tells us about the lung cancer risk posed by HTPs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aims and Methods<\/jats:title>\n                  <jats:p>We identified all biomarkers of exposure and potential harm measured in HTP trials and evaluated their appropriateness based on ideal characteristics for measuring lung cancer risk and tobacco use. The effects of HTPs on the most appropriate biomarkers within cigarette smokers switched to HTPs and compared to continued cigarette smoking or cessation were synthesized.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Sixteen out of eighty-two biomarkers (7 exposure and 9 potential harm) measured in HTP trials have been associated with tobacco use and lung cancer, dose-dependently correlated with smoking, modifiable upon cessation, measured within an appropriate timeframe, and had results published. Three of the exposure biomarkers significantly improved in smokers who switched to HTPs and were not significantly different from cessation. The remaining 13 biomarkers did not improve\u2014in some instances worsening upon switching to HTPs\u2014or were inconsistently affected across studies. There were no appropriate data to estimate the lung cancer risk of HTPs in non-smokers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The appropriateness of existing biomarker data in assessing lung cancer risk of HTPs, both relative to cigarettes and their absolute risk, is limited. Furthermore, findings on the most appropriate biomarkers were conflicting across studies and largely showed no improvement following a switch to HTPs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Implications<\/jats:title>\n                  <jats:p>Biomarker data are fundamental to assessing the reduced risk potential of HTPs. Our evaluation suggests much of the existing biomarker data on HTPs is inappropriate for determining the risk of lung cancer posed by HTPs. In particular, there is a paucity of data on the absolute lung cancer risk of HTPs, which could be obtained from comparisons to smokers who quit and never smokers exposed to or using HTPs. There is an urgent need for further exploration of the lung cancer risks posed by HTPs, via clinical trials and, in the long-term, confirmation of these risks via epidemiological studies. However, careful consideration should be given to biomarker selection and study design to ensure both are appropriate and will provide valuable data.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ntr\/ntad081","type":"journal-article","created":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T14:52:37Z","timestamp":1684680757000},"page":"270-280","source":"Crossref","is-referenced-by-count":16,"title":["What Can Current Biomarker Data Tell Us About the Risks of Lung Cancer Posed by Heated Tobacco Products?"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7443-2795","authenticated-orcid":false,"given":"Sophie","family":"Braznell","sequence":"first","affiliation":[{"name":"Tobacco Control Research Group, Department for Health, University of Bath , Bath , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9989-6158","authenticated-orcid":false,"given":"John","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department for Health, University of Bath , Bath , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna B","family":"Gilmore","sequence":"additional","affiliation":[{"name":"Tobacco Control Research Group, Department for Health, University of Bath , Bath , UK"},{"name":"SPECTRUM (Shaping Public Health Policies to Reduce Inequalities and Harm) Consortium , Bath , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,5,21]]},"reference":[{"issue":"1","key":"2024022210042622600_CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","article-title":"Lung cancer 2020: epidemiology, etiology, and prevention","volume":"41","author":"Bade","year":"2020","journal-title":"Clin Chest Med."},{"key":"2024022210042622600_CIT0002","author":"Institute for Health Metrics and Evaluation","year":"2019"},{"issue":"8","key":"2024022210042622600_CIT0003","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/s41416-018-0029-6","article-title":"The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015","volume":"118","author":"Brown","year":"2018","journal-title":"Br J Cancer."},{"issue":"11","key":"2024022210042622600_CIT0004","first-page":"1201","article-title":"Lifetime smoking history and risk of lung cancer: results from the Framingham heart study","volume":"110","author":"Tindle","year":"2018","journal-title":"J Natl Cancer Inst."},{"issue":"1","key":"2024022210042622600_CIT0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1158\/1940-6207.CAPR-13-0371","article-title":"Fifty Years of tobacco carcinogenesis research: from mechanisms to early detection and prevention of lung cancer","volume":"7","author":"Hecht","year":"2014","journal-title":"Cancer Prev Res"},{"key":"2024022210042622600_CIT0006","author":"World Health Organization","year":"2020"},{"issue":"1","key":"2024022210042622600_CIT0007","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1186\/s12889-019-6957-0","article-title":"An online survey of users of tobacco vaporizers, reasons and modes of utilization, perceived advantages and perceived risks","volume":"19","author":"Queloz","year":"2019","journal-title":"BMC Public Health"},{"issue":"23","key":"2024022210042622600_CIT0008","first-page":"46304630","article-title":"Prevalence, use behaviors, and preferences among users of heated tobacco products: findings from the 2018 ITC Japan survey","volume":"16","author":"Sutanto","year":"2019","journal-title":"Int J Environ Res Public Health."},{"issue":"1","key":"2024022210042622600_CIT0009","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/tobaccocontrol-2019-055306","article-title":"Factors that influence smokers\u2019 and ex-smokers\u2019 use of IQOS: a qualitative study of IQOS users and ex-users in the UK","volume":"30","author":"Tompkins","year":"2021","journal-title":"Tob Control."},{"issue":"4","key":"2024022210042622600_CIT0010","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/tobaccocontrol-2020-055652","article-title":"Rapid increase in heated tobacco product (HTP) use from 2015 to 2019: from the Japan \u201cSociety and New Tobacco\u201d Internet Survey (JASTIS)","volume":"30","author":"Hori","year":"2021","journal-title":"Tob Control."},{"issue":"Supplement_3","key":"2024022210042622600_CIT0011","doi-asserted-by":"crossref","first-page":"iii78","DOI":"10.1093\/eurpub\/ckz228","article-title":"Awareness and use of heated tobacco products among adult smokers in six European countries: findings from the EUREST-PLUS ITC Europe Surveys","volume":"30","author":"Maria Lotrean","year":"2020","journal-title":"Eur J Public Health."},{"issue":"1","key":"2024022210042622600_CIT0012","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41598-021-04438-7","article-title":"Use of electronic cigarettes and heated tobacco products during the Covid-19 pandemic","volume":"12","author":"Gallus","year":"2022","journal-title":"Sci Rep."},{"issue":"5","key":"2024022210042622600_CIT0013","doi-asserted-by":"crossref","first-page":"595","DOI":"10.13075\/ijomeh.1896.01433","article-title":"New ideas, old problems? Heated tobacco products\u2014a systematic review","volume":"32","author":"Jankowski","year":"2019","journal-title":"Int J Occup Med Environ Health."},{"issue":"12","key":"2024022210042622600_CIT0014","doi-asserted-by":"crossref","first-page":"66516651","DOI":"10.3390\/ijerph18126651","article-title":"Exposure to heated tobacco products and adverse health effects, a systematic review","volume":"18","author":"Znyk","year":"2021","journal-title":"Int J Environ Res Public Health."},{"key":"2024022210042622600_CIT0015","author":"U.S. Food and Drug Administration","year":"2020"},{"key":"2024022210042622600_CIT0016","author":"British American Tobacco","year":"2022"},{"key":"2024022210042622600_CIT0017","author":"Ciurcanu","year":"2020"},{"key":"2024022210042622600_CIT0018","volume-title":"Notice of final decisions to amend (or not amend) the current Poisons Standard","author":"Australian Therapeutic Goods Administration","year":"2020"},{"key":"2024022210042622600_CIT0019","author":"McNeill","year":"2018"},{"key":"2024022210042622600_CIT0020","author":"National Institute for Public Health and the Environment: Ministry of Health, Welfare and Sport","year":"2018"},{"key":"2024022210042622600_CIT0021","doi-asserted-by":"crossref","DOI":"10.1136\/tc-2022-057522","article-title":"Critical appraisal of interventional clinical trials assessing heated tobacco products: a systematic review","author":"Braznell","year":"2022","journal-title":"Tob Control."},{"issue":"1","key":"2024022210042622600_CIT0022","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ntr\/ntx273","article-title":"Biomarkers of potential harm: summary of an FDA-sponsored public workshop","volume":"21","author":"Chang","year":"2017","journal-title":"Nicotine Tob Res."},{"issue":"2","key":"2024022210042622600_CIT0023","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/tc.10.2.189","article-title":"Clearing the smoke: the science base for tobacco harm reduction\u2014executive summary","volume":"10","author":"Stratton","year":"2001","journal-title":"Tob Control."},{"key":"2024022210042622600_CIT0024","volume-title":"Clearing the smoke: assessing the science base for tobacco harm reduction","author":"Institute of Medicine","year":"2001"},{"issue":"3","key":"2024022210042622600_CIT0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/1055-9965.EPI-16-0675","article-title":"Biomarkers of tobacco exposure: summary of an FDA-sponsored public workshop","volume":"26","author":"Chang","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"4","key":"2024022210042622600_CIT0026","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/14622200600858166","article-title":"Biomarkers to assess the utility of potential reduced exposure tobacco products","volume":"8","author":"Hatsukami","year":"2006","journal-title":"Nicotine Tob Res."},{"issue":"1293","key":"2024022210042622600_CIT0027","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.12688\/f1000research.55411.1","article-title":"Review of recent lung biomarkers of potential harm\/effect for tobacco research [version 1; peer review: 1 approved with reservations, 1 not approved]","volume":"10","author":"Beattie","year":"2021","journal-title":"F1000Res"},{"issue":"3","key":"2024022210042622600_CIT0028","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/1354750X.2013.777116","article-title":"Lung cancer biomarkers for the assessment of modified risk tobacco products: an oxidative stress perspective","volume":"18","author":"Lowe","year":"2013","journal-title":"Biomarkers"},{"issue":"3","key":"2024022210042622600_CIT0029","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/1354750X.2017.1419284","article-title":"Review of biomarkers to assess the effects of switching from cigarettes to modified risk tobacco products","volume":"23","author":"Peck","year":"2018","journal-title":"Biomarkers"},{"issue":"2","key":"2024022210042622600_CIT0030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/003335490512000215","article-title":"Tobacco industry manipulation of research","volume":"120","author":"Bero","year":"2005","journal-title":"Public Health Rep."},{"key":"2024022210042622600_CIT0031","author":"Braznell"},{"issue":"8","key":"2024022210042622600_CIT0032","doi-asserted-by":"crossref","first-page":"15810","DOI":"10.21037\/atm.2016.03.46","article-title":"Biomarkers of risk to develop lung cancer in the new screening era","volume":"4","author":"Atwater","year":"2016","journal-title":"Ann Transl Med"},{"issue":"19","key":"2024022210042622600_CIT0033","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/jnci\/94.19.1435","article-title":"Tobacco smoking, harm reduction, and biomarkers","volume":"94","author":"Shields","year":"2002","journal-title":"J Natl Cancer Inst."},{"issue":"11","key":"2024022210042622600_CIT0034","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1158\/1055-9965.EPI-18-0915","article-title":"Effects of switching to a heat-not-burn tobacco product on biologically relevant biomarkers to assess a candidate modified risk tobacco product: a randomized trial","volume":"28","author":"L\u00fcdicke","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"2024022210042622600_CIT0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.toxlet.2020.04.013","article-title":"Exposure to harmful and potentially harmful constituents decreased in smokers switching to Carbon-Heated Tobacco Product","volume":"330","author":"Bosilkovska","year":"2020","journal-title":"Toxicol Lett."},{"key":"2024022210042622600_CIT0036","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.toxrep.2021.05.003","article-title":"A randomized controlled study in healthy participants to explore the exposure continuum when smokers switch to a tobacco heating product or an E-cigarette relative to cessation","volume":"8","author":"McEwan","year":"2021","journal-title":"Toxicol Rep."},{"key":"2024022210042622600_CIT0037","author":"Tran","year":"2021"},{"issue":"8","key":"2024022210042622600_CIT0038","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1007\/s11739-021-02798-6","article-title":"Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial","volume":"16","author":"Gale","year":"2021","journal-title":"Intern Emerg Med."},{"issue":"9","key":"2024022210042622600_CIT0039","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/ntr\/nty104","article-title":"Changes in biomarkers of exposure on switching from a conventional cigarette to tobacco heating products: a randomized, controlled study in healthy Japanese subjects","volume":"21","author":"Gale","year":"2018","journal-title":"Nicotine Tob Res."},{"issue":"4","key":"2024022210042622600_CIT0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/ntr\/ntz013","article-title":"Reduction in exposure to selected harmful and potentially harmful constituents approaching those observed upon smoking abstinence in smokers switching to the menthol tobacco heating system 2.2 for 3 months (Part 1)","volume":"22","author":"Haziza","year":"2019","journal-title":"Nicotine Tob Res."},{"key":"2024022210042622600_CIT0041","volume-title":"Clinical reduced exposure study with 5 days in a confinement setting (REX-C) - Japan. (10.26126\/intervals.qtdlic.1). INTERVALS","author":"Haziza","year":"2019"},{"issue":"2","key":"2024022210042622600_CIT0042","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/ntr\/ntw164","article-title":"Reduced exposure to harmful and potentially harmful smoke constituents with the tobacco heating system 2.1","volume":"19","author":"L\u00fcdicke","year":"2016","journal-title":"Nicotine Tob Res."},{"key":"2024022210042622600_CIT0043","author":"Haziza","year":"2019"},{"key":"2024022210042622600_CIT0044","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.yrtph.2018.05.001","article-title":"Assessment of the exposure to harmful and potentially harmful constituents in healthy Japanese smokers using a novel tobacco vapor product compared with conventional cigarettes and smoking abstinence","volume":"96","author":"Yuki","year":"2018","journal-title":"Regul Toxicol Pharmacol."},{"issue":"2","key":"2024022210042622600_CIT0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/ntr\/ntw287","article-title":"Effects of switching to the tobacco heating system 2.2 menthol, smoking abstinence, or continued cigarette smoking on biomarkers of exposure: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 1)","volume":"20","author":"L\u00fcdicke","year":"2017","journal-title":"Nicotine Tob Res."},{"key":"2024022210042622600_CIT0046","author":"Japan Tobacco Inc","year":"2021"},{"key":"2024022210042622600_CIT0047","author":"Philip Morris Products S.A","year":"2016"},{"key":"2024022210042622600_CIT0048","author":"Philip Morris Products S.A","year":"2016"},{"key":"2024022210042622600_CIT0049","author":"Philip Morris Products S.A"},{"key":"2024022210042622600_CIT0050","author":"Philip Morris Products S.A","year":"2017"},{"key":"2024022210042622600_CIT0051","author":"Philip Morris Products S.A","year":"2016"},{"issue":"2","key":"2024022210042622600_CIT0052","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ntr\/ntx028","article-title":"Effects of switching to the menthol tobacco heating system 2.2, smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 2)","volume":"20","author":"L\u00fcdicke","year":"2017","journal-title":"Nicotine Tob Res."},{"issue":"4","key":"2024022210042622600_CIT0053","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/ntr\/ntz084","article-title":"Favorable changes in biomarkers of potential harm to reduce the adverse health effects of smoking in smokers switching to the menthol tobacco heating system 2.2 for 3 months (Part 2)","volume":"22","author":"Haziza","year":"2019","journal-title":"Nicotine Tob Res."},{"issue":"1","key":"2024022210042622600_CIT0054","doi-asserted-by":"crossref","first-page":"11808","DOI":"10.1038\/s41598-021-91245-9","article-title":"Differential effects of heat-not-burn and conventional cigarettes on coronary flow, myocardial and vascular function","volume":"11","author":"Ikonomidis","year":"2021","journal-title":"Sci Rep."},{"issue":"6","key":"2024022210042622600_CIT0055","doi-asserted-by":"crossref","first-page":"e010455","DOI":"10.1161\/JAHA.118.010455","article-title":"Acute effects of heat-not-burn, electronic vaping, and traditional tobacco combustion cigarettes: the sapienza university of rome\u2013\u2013vascular assessment of proatherosclerotic effects of smoking (SUR-VAPES) 2 randomized trial","volume":"8","author":"Biondi-Zoccai","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"2024022210042622600_CIT0056","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/tobaccocontrol-2018-054419","article-title":"Heat-not-burn tobacco products: a systematic literature review","volume":"28","author":"Simonavicius","year":"2018","journal-title":"Tobacco Control"},{"key":"2024022210042622600_CIT0057","article-title":"Evaluation of biomarkers and surrogate endpoints in chronic disease","author":"National Academies of Sciences, Engineering, and Medicine","year":"2010"},{"key":"2024022210042622600_CIT0058","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1016\/j.jval.2019.04.1254","article-title":"PMU93 modeling years of life saved in Japan, Italy, Singapore, and U.S. By introducing a reduced-risk tobacco product","volume":"22","author":"Djurdjevic","year":"2019","journal-title":"Value Health."},{"issue":"6","key":"2024022210042622600_CIT0059","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s11739-019-02045-z","article-title":"Assessing the lung cancer risk reduction potential of candidate modified risk tobacco products","volume":"14","author":"Hoeng","year":"2019","journal-title":"Intern Emerg Med."},{"issue":"1","key":"2024022210042622600_CIT0060","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00204-020-02924-x","article-title":"Cancer potencies and margin of exposure used for comparative risk assessment of heated tobacco products and electronic cigarettes aerosols with cigarette smoke","volume":"95","author":"Rodrigo","year":"2021","journal-title":"Arch Toxicol."},{"issue":"1","key":"2024022210042622600_CIT0061","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.yrtph.2015.03.011","article-title":"A novel approach to assess the population health impact of introducing a Modified Risk Tobacco Product","volume":"72","author":"Weitkunat","year":"2015","journal-title":"Regul Toxicol Pharmacol."},{"issue":"Suppl 1","key":"2024022210042622600_CIT0062","doi-asserted-by":"crossref","first-page":"s82","DOI":"10.1136\/tobaccocontrol-2018-054572","article-title":"Modelling the impact of a new tobacco product: review of Philip Morris International\u2019s Population Health Impact Model as applied to the IQOS heated tobacco product","volume":"27","author":"Max","year":"2018","journal-title":"Tob Control."},{"issue":"10","key":"2024022210042622600_CIT0063","doi-asserted-by":"crossref","first-page":"e182078","DOI":"10.1001\/jamaoncol.2018.2078","article-title":"Assessment of lung cancer risk on the basis of a biomarker panel of circulating proteins","volume":"4","author":"Etiology IAoLC, Cancer RCfEDoL","year":"2018","journal-title":"JAMA Oncology"},{"issue":"6","key":"2024022210042622600_CIT0064","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1158\/1055-9965.EPI-15-1191","article-title":"Urinary metabolite risk biomarkers of lung cancer: a prospective cohort study","volume":"25","author":"Haznadar","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"10","key":"2024022210042622600_CIT0065","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1158\/1055-9965.EPI-21-1033","article-title":"Circulating isovalerylcarnitine and lung cancer risk: evidence from mendelian randomization and prediagnostic blood measurements","volume":"31","author":"Smith-Byrne","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"24","key":"2024022210042622600_CIT0066","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/jnci\/djt309","article-title":"Circulating inflammation markers and prospective risk for lung cancer","volume":"105","author":"Shiels","year":"2013","journal-title":"J Natl Cancer Inst."},{"key":"2024022210042622600_CIT0067","doi-asserted-by":"crossref","first-page":"100159","DOI":"10.1016\/j.lanepe.2021.100159","article-title":"Prevalence and reasons for use of Heated Tobacco Products (HTP) in Europe: an analysis of Eurobarometer data in 28 countries","volume":"8","author":"Laverty","year":"2021","journal-title":"Lancet Reg Health Eur"},{"issue":"4","key":"2024022210042622600_CIT0068","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/tobaccocontrol-2020-056168","article-title":"Heated tobacco product use and combustible cigarette smoking relapse\/initiation among former\/never smokers in Japan: the JASTIS 2019 study with 1-year follow-up","volume":"31","author":"Matsuyama","year":"2022","journal-title":"Tob Control."},{"issue":"Suppl 1","key":"2024022210042622600_CIT0069","doi-asserted-by":"crossref","first-page":"s55","DOI":"10.1136\/tobaccocontrol-2018-054323","article-title":"Awareness and use of heated tobacco products among US adults, 2016\u20132017","volume":"27","author":"Nyman","year":"2018","journal-title":"Tob Control."}],"container-title":["Nicotine and Tobacco Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ntr\/advance-article-pdf\/doi\/10.1093\/ntr\/ntad081\/50528691\/ntad081.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ntr\/article-pdf\/26\/3\/270\/56704185\/ntad081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ntr\/article-pdf\/26\/3\/270\/56704185\/ntad081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T18:20:12Z","timestamp":1708626012000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ntr\/article\/26\/3\/270\/7175101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,21]]},"references-count":69,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,5,21]]},"published-print":{"date-parts":[[2024,2,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ntr\/ntad081","relation":{},"ISSN":["1469-994X"],"issn-type":[{"value":"1469-994X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3,1]]},"published":{"date-parts":[[2023,5,21]]}}}